These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 17889206
1. Conversion from cyclosporine to tacrolimus stabilizes the course of lung function in lung transplant recipients with bronchiolitis obliterans syndrome. Borro JM, Bravo C, Solé A, Usetti P, Zurbano F, Lama R, De la Torre M, Román A, Pastor A, Laporta R, Cifrián JM, Santos F. Transplant Proc; 2007 Sep; 39(7):2416-9. PubMed ID: 17889206 [Abstract] [Full Text] [Related]
2. International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection. Sarahrudi K, Estenne M, Corris P, Niedermayer J, Knoop C, Glanville A, Chaparro C, Verleden G, Gerbase MW, Venuta F, Böttcher H, Aubert JD, Levvey B, Reichenspurner H, Auterith A, Klepetko W. J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1126-32. PubMed ID: 15052212 [Abstract] [Full Text] [Related]
3. Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. Kesten S, Chaparro C, Scavuzzo M, Gutierrez C. J Heart Lung Transplant; 1997 Sep; 16(9):905-12. PubMed ID: 9322139 [Abstract] [Full Text] [Related]
4. A retrospective 12-month study of conversion to everolimus in lung transplant recipients. Roman A, Ussetti P, Zurbano F, Borro JM, Solé A, Carreño MC, Santos F. Transplant Proc; 2011 Sep; 43(7):2693-8. PubMed ID: 21911148 [Abstract] [Full Text] [Related]
5. The impact of cytolytic therapy on bronchiolitis obliterans syndrome. Date H, Lynch JP, Sundaresan S, Patterson GA, Trulock EP. J Heart Lung Transplant; 1998 Sep; 17(9):869-75. PubMed ID: 9773858 [Abstract] [Full Text] [Related]
6. A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. Hachem RR, Yusen RD, Chakinala MM, Meyers BF, Lynch JP, Aloush AA, Patterson GA, Trulock EP. J Heart Lung Transplant; 2007 Oct; 26(10):1012-8. PubMed ID: 17919621 [Abstract] [Full Text] [Related]
7. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder? Burton CM, Iversen M, Mortensen J, Carlsen J, Andersen CB, Milman N, Scheike T. J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078 [Abstract] [Full Text] [Related]
8. Primary graft dysfunction and long-term pulmonary function after lung transplantation. Whitson BA, Prekker ME, Herrington CS, Whelan TP, Radosevich DM, Hertz MI, Dahlberg PS. J Heart Lung Transplant; 2007 Oct; 26(10):1004-11. PubMed ID: 17919620 [Abstract] [Full Text] [Related]
9. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1. Burton CM, Iversen M, Carlsen J, Mortensen J, Andersen CB, Steinbrüchel D, Scheike T. J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040 [Abstract] [Full Text] [Related]
10. The value of switching from cyclosporine to tacrolimus in the treatment of refractory acute rejection and obliterative bronchiolitis after lung transplantation. Sarahrudi K, Carretta A, Wisser W, Senbaklavaci O, Ploner M, Neuhauser P, Dobrovits M, Miwai Marta G, Papp A, Klepetko W. Transpl Int; 2002 Jan; 15(1):24-8. PubMed ID: 11875609 [Abstract] [Full Text] [Related]
11. Tacrolimus versus cyclosporine for adult lung transplant recipients: a meta-analysis. Fan Y, Xiao YB, Weng YG. Transplant Proc; 2009 Jun; 41(5):1821-4. PubMed ID: 19545736 [Abstract] [Full Text] [Related]
12. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation. Treede H, Glanville AR, Klepetko W, Aboyoun C, Vettorazzi E, Lama R, Bravo C, Knoop C, Aubert JD, Reichenspurner H, European and Australian Investigators in Lung Transplantation. J Heart Lung Transplant; 2012 Aug; 31(8):797-804. PubMed ID: 22554673 [Abstract] [Full Text] [Related]
13. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients. Shitrit D, Bendayan D, Gidon S, Saute M, Bakal I, Kramer MR. J Heart Lung Transplant; 2005 Sep; 24(9):1440-3. PubMed ID: 16143268 [Abstract] [Full Text] [Related]
14. Long-term clarithromycin therapy in the management of lung transplant recipients. Benden C, Boehler A. Transplantation; 2009 May 27; 87(10):1538-40. PubMed ID: 19461491 [Abstract] [Full Text] [Related]
15. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients. Hohlfeld J, Niedermeyer J, Hamm H, Schäfers HJ, Wagner TO, Fabel H. J Heart Lung Transplant; 1996 Sep 27; 15(9):888-94. PubMed ID: 8889984 [Abstract] [Full Text] [Related]
16. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J. Exp Clin Transplant; 2008 Jun 27; 6(2):113-7. PubMed ID: 18816237 [Abstract] [Full Text] [Related]
17. Predictors of renal function improvement following tacrolimus conversion in cyclosporine-treated kidney transplant recipients. Chang HR, Lin CC, Lian JD. Transplant Proc; 2007 Dec 27; 39(10):3135-41. PubMed ID: 18089339 [Abstract] [Full Text] [Related]
18. Rapamycin in lung transplantation. Hernández RL, Gil PU, Gallo CG, de Pablo Gafas A, Hernández MC, Alvarez MJ. Transplant Proc; 2005 Nov 27; 37(9):3999-4000. PubMed ID: 16386609 [Abstract] [Full Text] [Related]
19. Successful use in lung transplantation of an immunosuppressive regimen aimed at reducing target blood levels of sirolimus and tacrolimus. Villanueva J, Boukhamseen A, Bhorade SM. J Heart Lung Transplant; 2005 Apr 27; 24(4):421-5. PubMed ID: 15797743 [Abstract] [Full Text] [Related]